FOLFOXIRI reintroduction in metastatic colorectal cancer | 合法藥品大搜索

由 J Souglakos 著作 · 2006 · 被引用 436 次 — In the FOLFOXIRI arm, CPT-11 (150 mg m(-2)) was given on d1, L-OHP (65 mg m​(-2)) on d2, LV (200 mg m(-2)) on days 2 and 3 and 5-FU (400 mg m(-2) as i.v. ... Read More

由 L Shui 著作 · 2018 · 被引用 15 次 — Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for​ ... Read More

FOLFOXIRI is a chemotherapy regimen for The treatment of advanced colorectal cancer. The role of FOLFOXIRI in colorectal cancer has been reviewed. Read More

To accommodate an ambulatory pump for outpatient treatment, can be administered undiluted (50 mg/mL). The original protocol used 3200 mg/m2, but many ... Read More

Tools. © 2021 UpToDate, Inc. and/or its affiliates. All Rights Reserved. Chemotherapy regimens for metastatic colorectal cancer: FOLFOXIRI plus bevacizumab ... Read More

由 A Vienot 著作 · 2020 · 被引用 3 次 — FOLFIRINOX regimen is the first-line reference chemotherapy (L1) in advanced pancreatic ductal adenocarcinoma (aPDAC). FOLFOXIRI, a ... Read More

由 T Le Huy 著作 · 2019 — In conclusion, the FOLFOXIRI chemotherapy is a highly effective regimen demonstrated by an increase in response rate, progression-free survival and has side- ... Read More

由 F Montagnani 著作 · 2011 · 被引用 57 次 — Randomised controlled trials that compared FOLFOXIRI with FOLFIRI as a first-​line treatment for metastatic colorectal cancer were eligible for inclusion. Read More

2020年3月9日 — FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) is an effective first-line combination therapy for metastatic colorectal cancer that ... Read More